Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

7 of 7 completed trials have results

Key Signals

7 with results

Enrollment Performance

Analytics

Phase 2
4(57.1%)
Phase 1
3(42.9%)
7Total
Phase 2(4)
Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04203537Phase 1Completed

Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)

Role: lead

NCT03789318Phase 2Completed

Study in Subjects Undergoing Complete Abdominoplasty

Role: lead

NCT04774328Phase 1Completed

Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair

Role: lead

NCT03731364Phase 2Completed

Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty

Role: lead

NCT03885596Phase 2Completed

Open-Label CA-008 (Vocacapsaicin) in Bunionectomy

Role: lead

NCT03599089Phase 2Completed

Study of CA-008 (Vocacapsaicin) in Bunionectomy Patients

Role: lead

NCT03307837Phase 1Completed

A Phase 1 Study of Intraoperative Administration of CA-008 for the Correction of Hallux Valgus Deformity

Role: lead

All 7 trials loaded